Published in Antioxid Redox Signal on September 15, 2011
Emerging concepts on the anti-inflammatory actions of carbon monoxide-releasing molecules (CO-RMs). Med Gas Res (2012) 0.98
Mutation of Arabidopsis HY1 causes UV-C hypersensitivity by impairing carotenoid and flavonoid biosynthesis and the down-regulation of antioxidant defence. J Exp Bot (2012) 0.97
Reactive Oxygen Species-Dependent Nitric Oxide Production Contributes to Hydrogen-Promoted Stomatal Closure in Arabidopsis. Plant Physiol (2014) 0.93
The immunomodulatory role of carbon monoxide during transplantation. Med Gas Res (2013) 0.92
Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation. Transl Res (2015) 0.90
Carbon monoxide-based therapy ameliorates acute pancreatitis via TLR4 inhibition. J Clin Invest (2013) 0.90
CO-Releasing Molecules Have Nonheme Targets in Bacteria: Transcriptomic, Mathematical Modeling and Biochemical Analyses of CORM-3 [Ru(CO)3Cl(glycinate)] Actions on a Heme-Deficient Mutant of Escherichia coli. Antioxid Redox Signal (2015) 0.88
CO-releasing Metal Carbonyl Compounds as Antimicrobial Agents in the Post-antibiotic Era. J Biol Chem (2015) 0.87
The carbon monoxide releasing molecule CORM-2 attenuates Pseudomonas aeruginosa biofilm formation. PLoS One (2012) 0.87
Roles of NIA/NR/NOA1-dependent nitric oxide production and HY1 expression in the modulation of Arabidopsis salt tolerance. J Exp Bot (2013) 0.86
Carbon monoxide--physiology, detection and controlled release. Chem Commun (Camb) (2014) 0.85
Analysis of the bacterial response to Ru(CO)3Cl(Glycinate) (CORM-3) and the inactivated compound identifies the role played by the ruthenium compound and reveals sulfur-containing species as a major target of CORM-3 action. Antioxid Redox Signal (2013) 0.85
CO and CO-releasing molecules (CO-RMs) in acute gastrointestinal inflammation. Br J Pharmacol (2014) 0.82
Cytochrome bd-I in Escherichia coli is less sensitive than cytochromes bd-II or bo'' to inhibition by the carbon monoxide-releasing molecule, CORM-3: N-acetylcysteine reduces CO-RM uptake and inhibition of respiration. Biochim Biophys Acta (2013) 0.81
Gasotransmitters, poisons, and antimicrobials: it's a gas, gas, gas! F1000Prime Rep (2013) 0.80
Bilirubin: An Endogenous Molecule with Antiviral Activity in vitro. Front Pharmacol (2012) 0.79
Carbon monoxide (CO) is a novel inhibitor of connexin hemichannels. J Biol Chem (2014) 0.78
Differential Effects of CORM-2 and CORM-401 in Murine Intestinal Epithelial MODE-K Cells under Oxidative Stress. Front Pharmacol (2017) 0.78
Carbon monoxide-releasing molecule-3 (CORM-3; Ru(CO)3Cl(glycinate)) as a tool to study the concerted effects of carbon monoxide and nitric oxide on bacterial flavohemoglobin Hmp: applications and pitfalls. J Biol Chem (2014) 0.77
Carbon Monoxide Inhibits Porcine Reproductive and Respiratory Syndrome Virus Replication by the cGMP/PKG and NF-κB Signaling Pathway. J Virol (2016) 0.75
Delivery of Antioxidant and Anti-inflammatory Agents for Tissue Engineered Vascular Grafts. Front Pharmacol (2017) 0.75
Organised genome dynamics in the Escherichia coli species results in highly diverse adaptive paths. PLoS Genet (2009) 8.51
Stress-induced mutagenesis in bacteria. Science (2003) 4.44
DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis (2014) 3.99
The population genetics of commensal Escherichia coli. Nat Rev Microbiol (2010) 3.78
A specific genetic background is required for acquisition and expression of virulence factors in Escherichia coli. Mol Biol Evol (2004) 3.12
Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med (2009) 3.07
Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem J (2003) 3.00
Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J Antimicrob Chemother (2009) 2.85
The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups. Environ Microbiol Rep (2012) 2.84
Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res (2002) 2.73
The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J Antimicrob Chemother (2008) 2.66
Prediction of movement to surgical stimulation by the pupillary dilatation reflex amplitude evoked by a standardized noxious test. Anesthesiology (2015) 2.61
Phylogenetic and genomic diversity of human bacteremic Escherichia coli strains. BMC Genomics (2008) 2.51
Assigning Escherichia coli strains to phylogenetic groups: multi-locus sequence typing versus the PCR triplex method. Environ Microbiol (2008) 2.48
Extraintestinal virulence is a coincidental by-product of commensalism in B2 phylogenetic group Escherichia coli strains. Mol Biol Evol (2007) 2.44
Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res (2003) 2.34
Large-scale population structure of human commensal Escherichia coli isolates. Appl Environ Microbiol (2004) 2.29
Anesthesia and perioperative management of patients undergoing transcatheter aortic valve implantation: analysis of 90 consecutive patients with focus on perioperative complications. J Cardiothorac Vasc Anesth (2010) 2.26
Tight computerized versus conventional glucose control in the ICU: a randomized controlled trial. Intensive Care Med (2014) 2.26
Airway fungal colonization compromises the immune system allowing bacterial pneumonia to prevail. Crit Care Med (2013) 2.05
Effects of polycythemia on systemic endothelial function in chronic hypoxic lung disease. J Appl Physiol (1985) (2011) 2.04
The evolutionary history of Shigella and enteroinvasive Escherichia coli revised. J Mol Evol (2003) 1.99
Experimental mouse lethality of Escherichia coli isolates, in relation to accessory traits, phylogenetic group, and ecological source. J Infect Dis (2006) 1.92
Telomere dysfunction causes sustained inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2011) 1.87
Biomedical applications and potential health risks of nanomaterials: molecular mechanisms. Curr Mol Med (2006) 1.82
Genetic background of Escherichia coli and extended-spectrum beta-lactamase type. Emerg Infect Dis (2005) 1.81
CORM-3, a carbon monoxide-releasing molecule, alters the inflammatory response and reduces brain damage in a rat model of hemorrhagic stroke. Crit Care Med (2012) 1.80
Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. Br J Pharmacol (2005) 1.80
The enemy within us: lessons from the 2011 European Escherichia coli O104:H4 outbreak. EMBO Mol Med (2012) 1.75
Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype. Infect Immun (2012) 1.74
Heme oxygenase attenuates allergen-induced airway inflammation and hyperreactivity in guinea pigs. Am J Physiol Lung Cell Mol Physiol (2004) 1.72
Protection against cisplatin-induced nephrotoxicity by a carbon monoxide-releasing molecule. Am J Physiol Renal Physiol (2005) 1.68
Candida albicans impairs macrophage function and facilitates Pseudomonas aeruginosa pneumonia in rat. Crit Care Med (2009) 1.68
Postoperative ketamine administration decreases morphine consumption in major abdominal surgery: a prospective, randomized, double-blind, controlled study. Anesth Analg (2008) 1.64
Replicon typing of plasmids in Escherichia coli producing extended-spectrum beta-lactamases. J Antimicrob Chemother (2008) 1.59
Identification of forces shaping the commensal Escherichia coli genetic structure by comparing animal and human isolates. Environ Microbiol (2006) 1.58
Risk factors for postoperative pneumonia after cardiac surgery and development of a preoperative risk score*. Crit Care Med (2014) 1.58
Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2009) 1.57
Effect of human vicinity on antimicrobial resistance and integrons in animal faecal Escherichia coli. J Antimicrob Chemother (2006) 1.57
Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. Am J Physiol Heart Circ Physiol (2004) 1.56
CRISPR distribution within the Escherichia coli species is not suggestive of immunity-associated diversifying selection. J Bacteriol (2011) 1.54
Outcome of postoperative pneumonia in the Eole study. Intensive Care Med (2003) 1.53
The plasmid of Escherichia coli strain S88 (O45:K1:H7) that causes neonatal meningitis is closely related to avian pathogenic E. coli plasmids and is associated with high-level bacteremia in a neonatal rat meningitis model. Infect Immun (2009) 1.53
Heme oxygenase-1 is expressed in carotid atherosclerotic plaques infected by Helicobacter pylori and is more prevalent in asymptomatic subjects. Stroke (2005) 1.52
Mitochondrial respiratory chain and NAD(P)H oxidase are targets for the antiproliferative effect of carbon monoxide in human airway smooth muscle. J Biol Chem (2005) 1.50
Efficacy and toxicity of intravenous iron in a mouse model of critical care anemia*. Crit Care Med (2012) 1.50
Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemother (2013) 1.49
Bilirubin decreases nos2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats. FASEB J (2005) 1.49
Analysis of virulence plasmid gene expression defines three classes of effectors in the type III secretion system of Shigella flexneri. Microbiology (2005) 1.46
CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule. FASEB J (2004) 1.46
Molecular characterization of addiction systems of plasmids encoding extended-spectrum beta-lactamases in Escherichia coli. J Antimicrob Chemother (2010) 1.45
Heme oxygenase and angiogenic activity of endothelial cells: stimulation by carbon monoxide and inhibition by tin protoporphyrin-IX. Antioxid Redox Signal (2003) 1.44
Supraspinal locomotor centers do/do not contribute significantly to the hyperpnea of dynamic exercise in humans. J Appl Physiol (1985) (2006) 1.42
The pharmacokinetic profile of voriconazole during continuous high-volume venovenous hemofiltration in a critically ill patient. Ther Drug Monit (2008) 1.42
Yersinia high-pathogenicity island contributes to virulence in Escherichia coli causing extraintestinal infections. Infect Immun (2002) 1.41
Induction of heme oxygenase-1 inhibits NAD(P)H oxidase activity by down-regulating cytochrome b558 expression via the reduction of heme availability. J Biol Chem (2004) 1.41
Determination of Escherichia coli O types by allele-specific polymerase chain reaction: application to the O types involved in human septicemia. Diagn Microbiol Infect Dis (2006) 1.40
Extracorporeal membrane oxygenation in 5 patients with bronchial fistula with severe acute lung injury. Ann Thorac Surg (2011) 1.40
Hypothermic Total Liquid Ventilation Is Highly Protective Through Cerebral Hemodynamic Preservation and Sepsis-Like Mitigation After Asphyxial Cardiac Arrest. Crit Care Med (2015) 1.39
Carbon monoxide rescues mice from lethal sepsis by supporting mitochondrial energetic metabolism and activating mitochondrial biogenesis. J Pharmacol Exp Ther (2009) 1.38
Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines. Part Fibre Toxicol (2009) 1.36
Single-nucleotide polymorphism phylotyping of Escherichia coli. Appl Environ Microbiol (2005) 1.36
Role of intraspecies recombination in the spread of pathogenicity islands within the Escherichia coli species. PLoS Pathog (2009) 1.35
Therapeutic applications of carbon monoxide-releasing molecules. Expert Opin Investig Drugs (2005) 1.34
Pathogenicity-associated islands in extraintestinal pathogenic Escherichia coli are fitness elements involved in intestinal colonization. J Bacteriol (2010) 1.32
Heme oxygenase-1 as a target for drug discovery. Antioxid Redox Signal (2014) 1.31
Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells. Antioxid Redox Signal (2002) 1.29
Vasoactive properties of CORM-3, a novel water-soluble carbon monoxide-releasing molecule. Br J Pharmacol (2004) 1.28
Propriospinal circuitry underlying interlimb coordination in mammalian quadrupedal locomotion. J Neurosci (2005) 1.28
Meningitis caused by Escherichia coli producing TEM-52 extended-spectrum beta-lactamase within an extensive outbreak in a neonatal ward: epidemiological investigation and characterization of the strain. J Clin Microbiol (2010) 1.27
Bioactivity and pharmacological actions of carbon monoxide-releasing molecules. Curr Pharm Des (2003) 1.27
Decreasing the effects of horizontal gene transfer on bacterial phylogeny: the Escherichia coli case study. Mol Phylogenet Evol (2004) 1.27
Heart rate reduction during exercise-induced myocardial ischaemia and stunning. Eur Heart J (2004) 1.26
Use of carbon monoxide as a therapeutic agent: promises and challenges. Intensive Care Med (2008) 1.25
Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob/ob mice. Am J Physiol Heart Circ Physiol (2008) 1.25
Coating carbon nanotubes with a polystyrene-based polymer protects against pulmonary toxicity. Part Fibre Toxicol (2011) 1.25
Animal and human pathogenic Escherichia coli strains share common genetic backgrounds. Infect Genet Evol (2011) 1.23
Integron-associated antibiotic resistance and phylogenetic grouping of Escherichia coli isolates from healthy subjects free of recent antibiotic exposure. Antimicrob Agents Chemother (2005) 1.22
Rifampin-resistant RNA polymerase mutants of Chlamydia trachomatis remain susceptible to the ansamycin rifalazil. Antimicrob Agents Chemother (2005) 1.22
CO-metal interaction: Vital signaling from a lethal gas. Trends Biochem Sci (2006) 1.22
Heme oxygenase-1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2,3-dioxygenase. FASEB J (2005) 1.21
Biodistribution and clearance of instilled carbon nanotubes in rat lung. Part Fibre Toxicol (2008) 1.20
Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3 beta, SB216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione], via inhibition of the mitochondrial permeability transition pore. J Pharmacol Exp Ther (2008) 1.19